Related references
Note: Only part of the references are listed.Role of transforming growth factor-beta superfamily signaling pathways in human disease
Kelly J. Gordon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Altered TAB1 : I kappa B kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappa B activation during breast cancer progression
Jason R. Neil et al.
CANCER RESEARCH (2008)
Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-β through a PGE2-dependent mechanisms
Jason R. Neil et al.
CARCINOGENESIS (2008)
X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model
C. Hwang et al.
CELL DEATH AND DIFFERENTIATION (2008)
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β
Motozo Yamashita et al.
MOLECULAR CELL (2008)
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Alessandro Sorrentino et al.
NATURE CELL BIOLOGY (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Che-1 activates XIAP expression in response to DNA damage
T. Bruno et al.
CELL DEATH AND DIFFERENTIATION (2008)
Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis
A. Gal et al.
ONCOGENE (2008)
IAPs as a target for anticancer therapy
S. Danson et al.
CURRENT CANCER DRUG TARGETS (2007)
TGF-β signaling:: A tale of two responses
Rod A. Rahimi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
Samy Lamouille et al.
JOURNAL OF CELL BIOLOGY (2007)
XIAP induces NF-κB activation via the BIR1/TAB1 interaction and BIR1 dimerization
Miao Lu et al.
MOLECULAR CELL (2007)
Ubiquitin-mediated activation of TAK1 and IKK
A. Adhikari et al.
ONCOGENE (2007)
A cytokine-mediated link between innate immunity, inflammation, and cancer
Wan-Wan Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion
Amy J. Galliher et al.
CANCER RESEARCH (2007)
Inflammation and breast cancer - Cyclooxygenase/prostaglandin signaling and breast cancer
Louise R. Howe
BREAST CANCER RESEARCH (2007)
Uev1A, a ubiquitin conjugating enzyme variant, inhibits stress-induced apoptosis through NF-κB activation
Noor A. Syed et al.
APOPTOSIS (2006)
Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells
Z. Liu et al.
ONCOGENE (2006)
Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA
Shang-Mian Yie et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis
Eric C. LaCasse et al.
CLINICAL CANCER RESEARCH (2006)
NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-κB activation
CJ Wu et al.
NATURE CELL BIOLOGY (2006)
Targeting XIAP for the treatment of malignancy
AD Schimmer et al.
CELL DEATH AND DIFFERENTIATION (2006)
beta(3) Integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells
Amy J. Galliher et al.
BREAST CANCER RESEARCH (2006)
X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor β1 (TGF-β1) through ubiquitin-mediated proteosomal degradation of the TGF-β1-activated kinase 1 (TAK1)
S Kaur et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cadherins and catenins in breast cancer
P Cowin et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
O Berezovskaya et al.
CANCER RESEARCH (2005)
XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland
MA Olayioye et al.
CELL DEATH AND DIFFERENTIATION (2005)
The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta
JP Sokol et al.
BREAST CANCER RESEARCH (2005)
Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis
J Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)
HC Dan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Itch E3 ligase-mediated regulation of TGF-β signaling by modulating Smad2 phosphorylation
YL Bai et al.
MOLECULAR CELL (2004)
Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways
JI Park et al.
ONCOGENE (2003)
Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis:: implications in liver tumor formation
M Arsura et al.
ONCOGENE (2003)
Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion -: Fibulin-5 is induced by transforming growth factor-β and affects protein kinase cascades
WP Schiemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling
SB Reffey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Characterization of XIAP-deficient mice
H Harlin et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Interaction and functional cooperation of NF-κB with Smads -: Transcriptional regulation of the junB promoter
T López-Rovira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB
RP Nagarajan et al.
BIOCHEMICAL JOURNAL (2000)
Share Paper
